In the late evening of the 5th May, here in Geneva, the international trade community was jolted from […]
Category Archive: WHO
The SARS-CoV-2 variant B.1.617 present in India and other countries has been designated as a variant of concern […]
WHAT THIS TELLS US ABOUT THE PANDEMIC TREATY DISCUSSIONS Some would argue that we are in the run […]
DOSE-SHARING: THE PLAN B FOR COVAX THAT RESTS ON BENEVOLENCE In December 2020, Gavi spelt out the COVAX principles […]
The governance of global health has changed in radical ways just in the last 12 months. But potentially […]
At Geneva Health Files, we make a concerted effort to use inter-disciplinary reporting approaches given the very nature […]
The WTO vaccine equity event showed potential for spare manufacturing capacity and the willingness to finance it. But […]
While the COVAX Facility reached a milestone of making vaccine doses available (38 million) in more than 100 […]
Notes from the Sustainable Financing Working Group Meeting In its first meeting during March 29-31, the intergovernmental Sustainable […]
With every passing month, the unanticipated challenges facing the COVAX Facility mounts. Take the AstraZeneca vaccine, which has […]